Edition:
India

Aptevo Therapeutics Inc (APVO.OQ)

APVO.OQ on NASDAQ Stock Exchange Capital Market

0.62USD
10:24pm IST
Change (% chg)

$0.00 (+0.67%)
Prev Close
$0.61
Open
$0.61
Day's High
$0.64
Day's Low
$0.61
Volume
3,601
Avg. Vol
85,662
52-wk High
$2.73
52-wk Low
$0.49

Latest Key Developments (Source: Significant Developments)

Aptevo Therapeutics Q2 Loss Per Share $0.30
Friday, 9 Aug 2019 

Aug 9 (Reuters) - Aptevo Therapeutics Inc ::APTEVO THERAPEUTICS REPORTS SECOND QUARTER 2019 FINANCIAL RESULTS.Q2 LOSS PER SHARE $0.30.Q2 EARNINGS PER SHARE ESTIMATE $-0.33 -- REFINITIV IBES DATA.SAYS RECONFIRMS $36-$40 MILLION 2019 CASH BURN GUIDANCE.SAYS CASH, CASH EQUIVALENTS, AND MARKETABLE SECURITIES AS OF JUNE 30, 2019 TOTALING $28.5 MILLION.  Full Article

Aptevo Therapeutics Says Had Cash, Cash Equivalents, & Short-Term Investments As Of Dec 31, 2018 Totaling $38.1 Mln
Monday, 18 Mar 2019 

March 18 (Reuters) - Aptevo Therapeutics Inc ::APTEVO THERAPEUTICS REPORTS 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.APTEVO THERAPEUTICS -HAD CASH, CASH EQUIVALENTS, & SHORT-TERM INVESTMENTS AS OF DEC 31, 2018 TOTALING $38.1 MILLION, INCLUDING $7.5 MILLION IN RESTRICTED CASH.  Full Article

Aptevo Announces Proposed Public Offering Of Common Stock And Warrants
Thursday, 7 Mar 2019 

March 6 (Reuters) - Aptevo Therapeutics Inc ::APTEVO ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK AND WARRANTS.  Full Article

Aptevo Therapeutics Announces Expanded Growth Initiatives
Wednesday, 24 Oct 2018 

Oct 24 (Reuters) - Aptevo Therapeutics Inc ::APTEVO THERAPEUTICS ANNOUNCES EXPANDED GROWTH INITIATIVES FOR IXINITY.APTEVO THERAPEUTICS INC - PLANS TO INTRODUCE 3000 IU IXINITY ASSAY.APTEVO THERAPEUTICS INC - WILL COMMENCE PEDIATRIC STUDY SEEKING U.S. LABEL EXPANSION.APTEVO THERAPEUTICS INC - EXPLORES EX-US LICENSING AND PARTNERSHIP COLLABORATIONS TO EXPAND INTERNATIONAL IXINITY FOOTPRINT.APTEVO - PLANS TO COMMENCE PHASE 4 STUDY OF IXINITY IN ABOUT 20 PATIENTS UNDER 12 YRS AGE FOR POTENTIAL LABEL EXPANSION OF IXINITY IN PEDIATRIC SETTING.APTEVO THERAPEUTICS INC - ANTICIPATES NEW 3000 IU VIAL ASSAY FOR IXINITY WILL BE AVAILABLE IN MID-2019.APTEVO THERAPEUTICS INC - ANTICIPATES LAUNCH OF NEW 3000 IU VIAL ASSAY FOR IXINITY WILL BE AVAILABLE IN MID-2019.  Full Article